The global PACS provider has more than 400 PACS installations. Sectra holds a dominant market share in Sweden and Norway. Its technology appears in the U.S. integrated into Philips' Vequion. Sectra PACS, release 10, is a high-performance
The global PACS provider has more than 400 PACS installations. Sectra holds a dominant market share in Sweden and Norway. Its technology appears in the U.S. integrated into Philips' Vequion.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.